首站-论文投稿智能助手
典型文献
Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation
文献摘要:
Background : Largely due to incidental detection, asymptomatic pancreatic cystic le-sions (PCLs) have become prevalent in recent years. Among them, intraductal papillary mucinous neoplasm (IPMN) infrequently advances to pancreatic ductal adenocarci-noma (PDAC). Conservative surveillance versus surgical intervention is a difficult clini-cal decision for both caregivers and PCL patients. Because RNF43 loss- of- function mutations and KRAS gain- of- function mutations concur in a subset of IPMN and PDAC, their biological significance and therapeutic potential should be elucidated. Methods : Pancreatic Rnf43 knockout and Kras activated mice ( Rnf43 ?/? ; Kras G12D ) were generated to evaluate their clinical significance in pancreatic pre- neoplastic ini-tiation and malignant transformation.Results : Loss of Rnf43 potentiated the occurrence and severity of IPMN and PDAC in oncogenic Kras mice. The Wnt/β- catenin signaling pathway was activated in pan-creatic Kras G12D and Rnf43 knockout mice and the PORCN inhibitor LGK974 blocked pancreatic IPMN initiation and progression to PDAC accordingly. Conclusions : Rnf43 is a tumor suppressor in the prevention of pancreatic malignant transformation. This genetically reconstituted autochthonous pancreatic Rnf43 ?/? ; Kras G12D preclinical cancer model recapitulates the pathological process from pan-creatic cyst to cancer in humans and can be treated with inhibitors of Wnt/β- catenin signaling. Since the presence of RNF43 and KRAS mutations in IPMNs predicts future development of advanced neoplasia from PCLs, patients with these genetic anomalies warrant surveillance, surgery, and/or targeted therapeutics such as Wnt/β- catenin inhibitors.
文献关键词:
作者姓名:
Xian Zhou;Zhichao Sun;Mengdi Zhang;Xiaoyu Qu;Shuhui Yang;Lianmei Wang;Yanling Jing;Li Li;Weiwei Deng;Fangming Liu;Jin Di;Jie Chen;Jian Wu;Hongbing Zhang
作者机构:
State Key Laboratory of Medical Molecular Biology,Department of Physiology,Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing, China;Institute of Cancer Stem Cell,Dalian Medical University,Dalian,China;Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences,Beijing,China;Department of Pathology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing, China;MyGenostics Inc.,Beijing,China
引用格式:
[1]Xian Zhou;Zhichao Sun;Mengdi Zhang;Xiaoyu Qu;Shuhui Yang;Lianmei Wang;Yanling Jing;Li Li;Weiwei Deng;Fangming Liu;Jin Di;Jie Chen;Jian Wu;Hongbing Zhang-.Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation)[J].动物模型与实验医学(英文),2022(01):61-71
A类:
Rnf43,preneoplasia,adenocarci,PORCN,LGK974,recapitulates,IPMNs
B类:
Deficient,potentiates,hyperactive,Kras,mediated,pancreatic,initiation,malignant,transformation,Background,Largely,due,incidental,detection,asymptomatic,cystic,PCLs,have,become,prevalent,recent,years,Among,them,intraductal,papillary,mucinous,neoplasm,infrequently,advances,PDAC,Conservative,surveillance,versus,surgical,intervention,difficult,decision,both,caregivers,patients,Because,RNF43,loss,function,mutations,KRAS,gain,concur,subset,their,biological,significance,potential,should,elucidated,Methods,Pancreatic,knockout,activated,mice,G12D,were,generated,evaluate,neoplastic,Results,Loss,potentiated,occurrence,severity,oncogenic,Wnt,catenin,signaling,pathway,was,blocked,progression,accordingly,Conclusions,tumor,suppressor,prevention,This,genetically,reconstituted,autochthonous,preclinical,cancer,model,pathological,process,from,humans,treated,inhibitors,Since,presence,predicts,future,development,advanced,these,anomalies,warrant,surgery,targeted,therapeutics,such
AB值:
0.482579
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
The mutation landscape of multiple cancer predisposition genes in Chinese familial/hereditary breast cancer families
Li Dong;Hailian Zhang;Huan Zhang;Yingnan Ye;Yanan Cheng;Lijuan Li;Lijuan Wei;Lei Han;Yandong Cao;Shixia Li;Xishan Hao;Juntian Liu;Jinpu Yu-Cancer Molecular Diagnostics Core;The Second Department of Breast Cancer;Cancer Prevention Center,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Tianjin 300060,China;Department of Oncology,Tianjin Third Central Hospital,Tianjin Institute of Hepatobiliary Disease,Tianjin Key Laboratory of Artificial Cell,Artificial Cell Engineering Technology Research Center of Public Health Ministry,Tianjin 300170,China;Analyses Technology Co.Ltd.,Beijing 102600,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Identification of circRNA/miRNA/mRNA regulatory net-work involving(+)-catechin ameliorates diabetic nephropathy mice
Chao Chen;Dina Zhu;Shuai Zhang;Wensheng Zhang-Zhuhai Branch of State Key Laboratory of Earth Surface Processes and Resource Ecology,Advanced Institute of Natural Sciences,Beijing Normal University,Zhuhai 519087,China;Engineering Research Center of Natural Medicine,Ministry of Education,Advanced Insti-tute of Natural Sciences,Beijing Normal University,Zhuhai 519087,China;International Cooperation Laboratory of Molecular Medicine,Academy of Chinese Medical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Beijing Key Laboratory of Traditional Chinese Medicine Protection and Utilization,Faculty of Geographical Science,Beijing Normal University,Beijing 100875,China
Value of contrast-enhanced ultrasound combined with percutaneous ultrasound-guided fine-needle aspiration in the diagnosis of solid pancreatic lesions
Gui Yang;Dai Menghua;Meng Zhilan;Chang Xiaoyan;Tan Li;Zhang Jing;Chen Xueqi;Zhou Tongtong;Zhang Qing;Xiao Mengsu;Lyu Ke;Jiang Yuxin-Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China;Department of Pathology, State Key Laboratory of Complex Severe and Rare Diseases, Pecking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng District, Beijing 100730, China
Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study
Li Jielin;Hu Jiexuan;Li Peng;Wu Yongdong;Wang Yongjun;Ji Ming;Hua Haiyang;Ran Wenbin;Pan Yanglin;Zhang Shutian-Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China;Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China;Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, Sichuan 610031, China;Xijing Hospital of Digestive Diseases, Air Force Medical University of People’s Liberation Army, Xi’an, Shaanxi 710032, China
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Xiao Mo;Cheng-fei Zhang;Ping Xu;Min Ding;Zhi-jie Ma;Qi Sun;Yu Liu;Hong-kai Bi;Xin Guo;Alaa Abdelatty;Chao Hu;Hao-jun Xu;Guo-ren Zhou;Yu-liang Jia;Hong-ping Xia-Sir Run Run Hospital,Nanjing Medical University,Nanjing 211166,China;School of Basic Medical Sciences&State Key Laboratory of Reproductive Medicine&Key Laboratory of Antibody Technique of National Health Commission&Jiangsu Antibody Drug Engineering Research Center,Nanjing Medical University,Nanjing 210092,China;Jiangsu Cancer Hospital&Jiangsu Institute of Cancer Research&The Affiliated Cancer Hospital of Nanjing Medical University,Nanjing 210092,China;Yijishan Hospital of Wannan Medical College,Wannan Medical College,Wuhu 241002,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。